Course of Post COVID-19 Disease Symptoms over Time in the ComPaRe Long COVID Prospective E-cohort

Overview

Journal Nat Commun

Specialty Biology

Date 2022 Apr 6

PMID 35383197

Authors

Viet-Thi Tran

Raphael Porcher

Isabelle Pane

Philippe Ravaud

Affiliations

Soon will be listed here.

Abstract

About 10% of people infected by severe acute respiratory syndrome coronavirus 2 experience post COVID-19 disease. We analysed data from 968 adult patients (5350 person-months) with a confirmed infection enroled in the ComPaRe long COVID cohort, a disease prevalent prospective e-cohort of such patients in France. Day-by-day prevalence of post COVID-19 symptoms was determined from patients' responses to the Long COVID Symptom Tool, a validated self-reported questionnaire assessing 53 symptoms. Among patients symptomatic after 2 months, 85% still reported symptoms one year after their symptom onset. Evolution of symptoms showed a decreasing prevalence over time for 27/53 symptoms (e.g., loss of taste/smell); a stable prevalence over time for 18/53 symptoms (e.g., dyspnoea), and an increasing prevalence over time for 8/53 symptoms (e.g., paraesthesia). The disease impact on patients' lives began increasing 6 months after onset. Our results are of importance to understand the natural history of post COVID-19 disease.

Citing Articles

The 2024 National Academies of Sciences, Engineering, and Medicine Long COVID Definition: What Clinicians Need to Know.

Chu L, Bishof K, Dumes A, Wesley Ely E, Joseph P, Troxel A J Gen Intern Med. 2025; .

PMID: 40063321 DOI: 10.1007/s11606-025-09415-8.

Development of an expectation management intervention for patients with Long COVID: A focus group study with affected patients.

Funk M, Reinke M, Lowe B, Engelmann P PLoS One. 2025; 20(2):e0317905.

PMID: 39899641 PMC: 11790141. DOI: 10.1371/journal.pone.0317905.

Polymorphisms Influence the Expression of the Fas and FasL Genes in COVID-19.

Dos Santos Brito W, de Brito W, Dos Santos Ferreira F, Santana E, Lopes J, da Silva Graca Amoras E Int J Mol Sci. 2025; 26(2).

PMID: 39859379 PMC: 11765610. DOI: 10.3390/ijms26020666.

Risk Factors Associated with Post-COVID-19 Conditions Among Diabetes Patients in the United Arab Emirates.

Alkhemeiri A, El-Khatib Z, Alameri A, AlKaabi A, Lakshmanan J, Awofeso N J Epidemiol Glob Health. 2025; 15(1):6.

PMID: 39833641 PMC: 11746986. DOI: 10.1007/s44197-025-00346-5.

Tracking Persistent Symptoms in Scotland (TraPSS): a longitudinal prospective cohort study of COVID-19 recovery after mild acute infection.

Sculthorpe N, Mclaughlin M, Cerexhe L, Macdonald E, Dello Iacono A, Sanal-Hayes N BMJ Open. 2025; 15(1):e086646.

PMID: 39819953 PMC: 11751823. DOI: 10.1136/bmjopen-2024-086646.

References

Davis H, Assaf G, McCorkell L, Wei H, Low R, Reem Y . Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021; 38:101019. PMC: 8280690. DOI: 10.1016/j.eclinm.2021.101019. View

Taquet M, Geddes J, Husain M, Luciano S, Harrison P . 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021; 8(5):416-427. PMC: 8023694. DOI: 10.1016/S2215-0366(21)00084-5. View

Fang X, Ming C, Cen Y, Lin H, Zhan K, Yang S . Post-sequelae one year after hospital discharge among older COVID-19 patients: A multi-center prospective cohort study. J Infect. 2021; 84(2):179-186. PMC: 8662958. DOI: 10.1016/j.jinf.2021.12.005. View

Ayoubkhani D, Khunti K, Nafilyan V, Maddox T, Humberstone B, Diamond I . Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ. 2021; 372:n693. PMC: 8010267. DOI: 10.1136/bmj.n693. View

Tran V, Ravaud P . COllaborative open platform E-cohorts for research acceleration in trials and epidemiology. J Clin Epidemiol. 2020; 124:139-148. DOI: 10.1016/j.jclinepi.2020.04.021. View

Bury M . Chronic illness as biographical disruption. Sociol Health Illn. 1982; 4(2):167-82. DOI: 10.1111/1467-9566.ep11339939. View

Carfi A, Bernabei R, Landi F . Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020; 324(6):603-605. PMC: 7349096. DOI: 10.1001/jama.2020.12603. View

Michelen M, Manoharan L, Elkheir N, Cheng V, Dagens A, Hastie C . Characterising long COVID: a living systematic review. BMJ Glob Health. 2021; 6(9). PMC: 8478580. DOI: 10.1136/bmjgh-2021-005427. View

Taquet M, Dercon Q, Luciano S, Geddes J, Husain M, Harrison P . Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 2021; 18(9):e1003773. PMC: 8478214. DOI: 10.1371/journal.pmed.1003773. View

10.

Augustin M, Schommers P, Stecher M, Dewald F, Gieselmann L, Gruell H . Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health Eur. 2021; 6:100122. PMC: 8129613. DOI: 10.1016/j.lanepe.2021.100122. View

11.

van Gelder M, Bretveld R, Roeleveld N . Web-based questionnaires: the future in epidemiology?. Am J Epidemiol. 2010; 172(11):1292-8. DOI: 10.1093/aje/kwq291. View

12.

Nehme M, Braillard O, Alcoba G, Perone S, Courvoisier D, Chappuis F . COVID-19 Symptoms: Longitudinal Evolution and Persistence in Outpatient Settings. Ann Intern Med. 2020; 174(5):723-725. PMC: 7741180. DOI: 10.7326/M20-5926. View

13.

Huang L, Yao Q, Gu X, Wang Q, Ren L, Wang Y . 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet. 2021; 398(10302):747-758. PMC: 8389999. DOI: 10.1016/S0140-6736(21)01755-4. View

14.

Christiansen D, Berke E . Gender- and Sex-Based Contributors to Sex Differences in PTSD. Curr Psychiatry Rep. 2020; 22(4):19. DOI: 10.1007/s11920-020-1140-y. View

15.

Nalbandian A, Sehgal K, Gupta A, Madhavan M, McGroder C, Stevens J . Post-acute COVID-19 syndrome. Nat Med. 2021; 27(4):601-615. PMC: 8893149. DOI: 10.1038/s41591-021-01283-z. View

16.

Tran V, Riveros C, Clepier B, Desvarieux M, Collet C, Yordanov Y . Development and Validation of the Long Coronavirus Disease (COVID) Symptom and Impact Tools: A Set of Patient-Reported Instruments Constructed From Patients' Lived Experience. Clin Infect Dis. 2021; 74(2):278-287. PMC: 8135558. DOI: 10.1093/cid/ciab352. View

17.

Miyazato Y, Morioka S, Tsuzuki S, Akashi M, Osanai Y, Tanaka K . Prolonged and Late-Onset Symptoms of Coronavirus Disease 2019. Open Forum Infect Dis. 2020; 7(11):ofaa507. PMC: 7665672. DOI: 10.1093/ofid/ofaa507. View

18.

Blomberg B, Mohn K, Brokstad K, Zhou F, Linchausen D, Hansen B . Long COVID in a prospective cohort of home-isolated patients. Nat Med. 2021; 27(9):1607-1613. PMC: 8440190. DOI: 10.1038/s41591-021-01433-3. View

19.

Huang C, Huang L, Wang Y, Li X, Ren L, Gu X . 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021; 397(10270):220-232. PMC: 7833295. DOI: 10.1016/S0140-6736(20)32656-8. View

20.

Soriano J, Murthy S, Marshall J, Relan P, Diaz J . A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2021; 22(4):e102-e107. PMC: 8691845. DOI: 10.1016/S1473-3099(21)00703-9. View